title: Optical coherence tomography angiography in treated type 2 neovascularization undergoing monthly anti-VEGF treatment.
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Mariacristina
authors: M
authors: Parravano
authors: Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele Hospital, Milan, Italy.
authors: Lea
authors: L
authors: Querques
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Fabio
authors: F
authors: Scarinci
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Paola
authors: P
authors: Giorno
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Daniele
authors: D
authors: De Geronimo
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Roberto
authors: R
authors: Gattegna
authors: G. B. Bietti Foundation-IRCCS, Rome, Italy.
authors: Monica
authors: M
authors: Varano
authors: Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele Hospital, Milan, Italy.
authors: Francesco
authors: F
authors: Bandello
authors: Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele Hospital, Milan, Italy.
authors: Giuseppe
authors: G
authors: Querques
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D002829:Choroid / Q000098:blood supply / Q000473:pathology*; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy; D005451:Fluorescein Angiography / Q000379:methods; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D015203:Reproducibility of Results; D041623:Tomography, Optical Coherence / Q000379:methods*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor